Fox Chase Cancer Center Welcomes Iberia Romina Sosa

PHILADELPHIA (July 22, 2019) – Fox Chase Cancer Center is pleased to announce the hiring of Iberia Romina Sosa, MD, PhD, to the department of Hematology/Oncology. She is an assistant professor in the Clinical Investigator track. Sosa will provide hematologic consultation services at all Fox Chase locations.

Sosa comes to Fox Chase from the Baylor College of Medicine, where she was an assistant professor in the department of Hematology/Oncology. She is a board certified in internal medicine and hematology, serves on the editorial board for Hematology News, and is a member of the SWOG/NCI Cancer Research Cooperative Group. She received her MD and PhD from the University of Minnesota, and completed a residency and hematology/oncology fellowship at Vanderbilt University. Recently, Sosa was named to the Texas Super Doctors Rising Stars list for 2019.

Fox Chase Cancer Center’s Department of Hematology is staffed with medical oncologists who are regional and national leaders in the field. As part of the multidisciplinary cancer treatment team, they help determine personalized treatment plans for specific cancers and have access to tremendous range of anticancer treatments.

Sosa will begin at Fox Chase on August 1, 2019.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427

Resize Text